AwardTape · Defense awards · Medical · Drugs and biologicals · SPE2DP26F2814
SPE2DP26F2814: $4.0M delivery order to Teva Pharmaceuticals USA, Inc
Teva Pharmaceuticals USA, Inc holds a delivery order from Defense Logistics Agency with $4.0M obligated since Oct 2023, against a ceiling of $4.0M. Latest action Feb 17, 2026.
8511918533 adenovirus type 4 a
| PIID | SPE2DP26F2814 |
|---|---|
| Type | delivery order |
| Parent award | SPE2DP20D0002 |
| Company | Teva Pharmaceuticals USA, Inc |
| Agency | Defense Logistics Agency |
| Contracting office | DLA TROOP SUPPORT |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $4.0M |
| Total obligated (lifetime) | $4.0M |
| Ceiling (base and all options) | $4.0M |
| Base date | Feb 17, 2026 |
| Latest action | Feb 17, 2026 |
| End date | Feb 24, 2026 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | NJ |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial